Front Page

Previous Story

Next Story

NIH Record


Boguski Named to Science Magazine Board

Dr. Mark Boguski, a senior investigator in the Computational Biology Branch of NLM's National Center for Biotechnology Information and an intramural researcher at NIH for 12 years, has agreed to join Science magazine's board of reviewing editors. Editor-in-chief Dr. Floyd Bloom said Boguski is not only widely respected in his own field but also has the breadth to evaluate science outside his own area. "The outside world looks to this blue ribbon group for their competence and fairness," he said. Boguski's 1-year term began in January, and is renewable by mutual consent for 4 years. He has written and lectured extensively on bioinformatics and genomics, and developed the first publicly available database system for expression array data. His current research interests include the analysis of data from large-scale expression studies and pharmacogenomics. He is an organizer of the Cold Spring Harbor Symposium on Genome Sequencing and Biology and has served on grant review and advisory panels for a number of government and private funding agencies and as a consultant to industry. Boguski holds an adjunct faculty position in the department of molecular biology and genetics at Johns Hopkins University School of Medicine and is a former editor of the journal Genome Research.

Hicks Joins CSR

Dr. Nancy Hicks recently joined the Center for Scientific Review as a scientific review administrator in the social sciences, nursing, epidemiology, and methods integrated review group. She served some 12 years as a commissioned officer in the Public Health Service Commissioned Corps, assigned as an epidemiologist to the Centers for Disease Control, the Oak Ridge Associated Universities and the Food and Drug Administration. In 1990, she was an environmental consultant in epidemiology to the WHO, where she provided scientific expertise to the United Arab Emirates, Ethiopia and Kenya. Hicks has specialized in studies of the health effects of ionizing radiation, elemental mercury and beryllium as well as on epidemiological and statistical methods, and has published extensively.

Huebner Named NIAAA Division Deputy Director

Dr. Robert Huebner has been named deputy director of NIAAA's Division of Clinical and Prevention Research. He will be responsible for advising the DCPR director in planning, administering and implementing alcohol treatment, prevention and health services research programs. In 1988, Huebner joined NIAAA and for the next 6 years directed the national evaluation of NIAAA's multi-site research demonstration programs on homelessness. In 1994, he was named chief of the Health Services Research Program where he led the development of NIAAA's health services research portfolio, oversaw completion of a strategic plan for health services research, and was active in a number of trans-NIH committees on managed care. Before joining NIAAA, he conducted research on health issues in the GAO's program evaluation and methodology division.

McNicol To Direct NEI Extramural Research Division

Dr. Loré Anne McNicol was recently appointed director of NEI's Division of Extramural Research. She joined NEI in 1989 as the Corneal Diseases Program director. Since then, she has worn many hats within NEI: director of the Lens and Cataract Program; chief of the Anterior Segment Diseases Branch; director of the Division of Extramural Activities; and most recently director of the Vision Research Program. She received her Ph.D. in medical sciences from Boston University School of Medicine, performing her thesis work on the structure of virulence antigens of Salmonella typhosa. She later did postdoctoral work in bacteriophage genetics at Tufts University School of Medicine. In 1983, McNicol joined the malaria unit of NIAID, before starting her administrative career in 1985 at NIGMS.

GMS Council Gains Four

NIGMS director Dr. Marvin Cassman (c) recently welcomed four new members to the National Advisory General Medical Sciences Council. They are (from l): Dr. Richard M. Weinshilboum, professor of pharmacology and medicine at the Mayo Medical School, whose research interests center on pharmacogenetics; Dr. Jay C. Dunlap, chair of the newly created department of genetics at Dartmouth Medical School, whose research interests include the molecular mechanisms of biological clocks; Dr. D. Amy Trainor, global product director, CNS (central nervous system), at AstraZeneca Pharmaceuticals, where she leads the development of new drugs for the treatment of neurodegenerative and psychiatric disorders; and Dr. John N. Abelson, George Beadle professor of biology at the California Institute of Technology, whose research focuses on the mechanism of RNA splicing.
Up to Top